Reduction of oxidized glutathione in normal and glucose-6-phosphate dehydrogenase deficient erythrocytes and their hemolysates.

When assayed by the ability to reduce oxidized glutathione to reduced glutathione, glucose-6-phosphate dehydrogenase deficiency of either the Negro or Caucasian mutant variety could be demonstrated in hemolysates only with hemoglobin concentrations below 2.0 Gm. per 100 ml. In intact erythrocytes, the inability to regenerate reduced glutathione was apparent regardless of the concentration of red cells. The process of hemolysis, therefore, appeared to permit the demonstration of higher levels of activity in G-6-PD deficient human erythrocytes than was possible in intact cells. A markedly deficient capacity to regenerate endogenous reduced glutathione or to reduce exogenous oxidized glutathione, however, could be demonstrated with the hemolysate of erythrocytes from a patient with hereditary nonspherocytic hemolytic anemia associated with a deficiency of glucose-6-phosphate dehydrogenase activity. These studies have emphasized the hazards involved in extrapolating the results of studies performed with hemolysates to metabolic processes within intact erythrocytes.

[1]  H. Notopuro,et al.  Glucose-6-phosphate dehydrogenase deficiency. , 1972, Paediatrica Indonesiana.

[2]  S. Piomelli,et al.  In vivo lability of glucose-6-phosphate dehydrogenase in GdA- and GdMediterranean deficiency. , 1968, The Journal of clinical investigation.

[3]  I. London,et al.  The regeneration of reduced glutathione in normal and glucose-6-phosphate dehydrogenase deficient human red blood cells. , 1967, Blood.

[4]  A. Motulsky,et al.  Negro Variant of Glucose-6-Phosphate Dehydrogenase Deficiency (A-) in Man , 1967, Science.

[5]  H. Jacob,et al.  Effects of sulfhydryl inhibition on red blood cells. 3. Glutathione in the regulation of the hexose monophosphate pathway. , 1966, The Journal of biological chemistry.

[6]  P. C. Huang,et al.  Decreased glutathione content of human erythrocytes produced by methyl phenylazoformate. , 1965, Biochemical and biophysical research communications.

[7]  E. Beutler,et al.  Improved method for the determination of blood glutathione. , 1963, The Journal of laboratory and clinical medicine.

[8]  H. Kirkman,et al.  Glucose 6-phosphate dehydrogenase from human erythrocytes. II. Subactive states of the enzyme from normal persons. , 1962, The Journal of biological chemistry.

[9]  P. Marks,et al.  Erythrocyte glucose 6-phosphate dehydrogenase of normal and mutant human subjects: properties of the purified enzymes. , 1961, The Journal of biological chemistry.

[10]  S. Schrier,et al.  The hemolytic effect of primaquine. IX. Enzymatic abnormalities in primaquine-sensitive erythrocytes. , 1958, The Journal of laboratory and clinical medicine.

[11]  P. Marks Red cell glucose-6-phosphate and 6-phosphogluconic dehydrogenases and nucleoside phosphorylase. , 1958, Science.

[12]  E. Beutler,et al.  The mechanism of glutathione destruction and protection in drug-sensitive and non-sensitive erythrocytes; in vitro studies. , 1957, The Journal of clinical investigation.

[13]  P. Carson,et al.  Enzymatic deficiency in primaquine-sensitive erythrocytes. , 1956, Science.